Back to Search Start Over

Transcatheter heart valve failure: a systematic review.

Authors :
Mylotte, Darren
Andalib, Ali
Pascal Thériault-Lauzier, Pascal
Dorfmeister, Magdalena
Girgis, Mina
Alharbi, Waleed
Chetrit, Michael
Galatas, Christos
Mamane, Samuel
Sebag, Igal
Buithieu, Jean
Bilodeau, Luc
de Varennes, Benoit
Lachapelle, Kevin
Lange, Ruediger
Martucci, Giuseppe
Virmani, Renu
Piazza, Nicolo
Source :
European Heart Journal; 6/1/2015, Vol. 36 Issue 21, p1306-1327c, 25p, 5 Color Photographs, 1 Diagram, 5 Charts, 1 Graph
Publication Year :
2015

Abstract

Aims A comprehensive description of transcatheter heart valve (THV) failure has not been performed. We undertook a systematic review to investigate the aetiology, diagnosis, management, and outcomes of THV failure. Methods and results The systematic review was performed in accordance with the PRISMA guidelines using EMBASE, MEDLINE, and Scopus. Between December 2002 and March 2014, 70 publications reported 87 individual cases of transcatheter aortic valve implantation (TAVI) failure. Similar to surgical bioprosthetic heart valve failure, we observed cases of prosthetic valve endocarditis (PVE) (n = 34), structural valve failure (n = 13), and THV thrombosis (n = 15). The microbiological profile of THV PVE was similar to surgical PVE, though one-quarter had satellite mitral valve endocarditis, and surgical intervention was required in 40% (75% survival). Structural valve failure occurred most frequently due to leaflet calcification and was predominantly treated by redo-THV (60%). Transcatheter heart valve thrombosis occurred at a mean 9±7 months post-implantation and was successfully treated by prolonged anticoagulation in three-quarters of cases. Two novel causes of THV failure were identified: late THV embolization (n = 18); and THV compression (n = 7) following cardiopulmonary resuscitation (CPR). These failure modes have not been reported in the surgical literature. Potential risk factors for late THV embolization include low prosthesis implantation, THV undersizing/underexpansion, bicuspid, and non-calcified anatomy. Transcatheter heart valve embolization mandated surgery in 80% of patients. Transcatheter heart valve compression was noted at post-mortem in most cases. Conclusion Transcatheter heart valves are susceptible to failure modes typical to those of surgical bioprostheses and unique to their specific design. Transcatheter heart valve compression and late embolization represent complications previously unreported in the surgical literature. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0195668X
Volume :
36
Issue :
21
Database :
Complementary Index
Journal :
European Heart Journal
Publication Type :
Academic Journal
Accession number :
103072177
Full Text :
https://doi.org/10.1093/eurheartj/ehu388